Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
3.22 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 48.065 | 40.638 | 44.39 | 48.32 | 38.008 | 33.196 | 38.008 | 29.725 | 25.306 | 22.073 | 21.429 | 11.035 | 8.906 | 8.051 | 7.089 | 9.448 | 2.027 | 1.788 | 1.864 | 0.323 | 0.32 | 0.248 | 0.801 | 0.582 | 0.819 | 0.263 | 0.467 | 0.17 | 0.565 | 0.354 |
| Cost of Revenue
| 10.5 | 8.682 | 10.281 | 8.201 | 7.555 | 5.319 | 7.555 | 5.26 | 4.81 | 6.273 | 4.889 | 3.22 | 3.383 | 1.826 | 3.407 | 2.832 | 1.299 | 1.79 | 1.603 | 0.01 | 0.023 | 0 | 0.042 | 0 | 0 | 0.042 | 0 | 0 | 0.004 | 0 |
| Gross Profit
| 37.565 | 31.956 | 34.109 | 40.119 | 30.453 | 27.877 | 30.453 | 24.465 | 20.496 | 15.8 | 16.54 | 7.815 | 5.523 | 6.225 | 3.682 | 6.616 | 0.728 | -0.002 | 0.261 | 0.313 | 0.297 | 0.248 | 0.759 | 0.582 | 0.819 | 0.221 | 0.467 | 0.17 | 0.561 | 0.354 |
| Gross Profit Ratio
| 0.782 | 0.786 | 0.768 | 0.83 | 0.801 | 0.84 | 0.801 | 0.823 | 0.81 | 0.716 | 0.772 | 0.708 | 0.62 | 0.773 | 0.519 | 0.7 | 0.359 | -0.001 | 0.14 | 0.969 | 0.928 | 1 | 0.948 | 1 | 1 | 0.84 | 1 | 1 | 0.993 | 1 |
| Reseach & Development Expenses
| 5.759 | 7.821 | 6.382 | 5.034 | 6.087 | 4.838 | 6.087 | 6.043 | 3.718 | 6.25 | 10.082 | 5.663 | 5.383 | 4.032 | 5.11 | 3.876 | 5.289 | 6.646 | 12.42 | 15.518 | 19.333 | 13.167 | 12.39 | 10.875 | 8.677 | 8.712 | 6.578 | 5.725 | 4.201 | 3.662 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.998 | 0 | 17.644 | 21.606 | 20.642 | 14.877 | 15.024 | 12.518 | 8.725 | 4.65 | 4.499 | 3.239 | 3.098 | 2.017 | 1.559 | 1.341 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 39.993 | 38.38 | 37.568 | 37.287 | 37.635 | 33.605 | 37.635 | 34.491 | 32.984 | 35.913 | 54.179 | 26.535 | 25.927 | 19.077 | 17.998 | 16.484 | 17.644 | 21.606 | 20.642 | 14.877 | 15.024 | 12.518 | 8.725 | 4.65 | 4.499 | 3.239 | 3.098 | 2.017 | 1.559 | 1.341 |
| Other Expenses
| 2.71 | 0 | 15.709 | -7.614 | -4.538 | -3.557 | -4.538 | -3.39 | 2.71 | 2.711 | -2.519 | -0.025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 45.752 | 46.201 | 43.95 | 42.321 | 46.432 | 41.154 | 46.432 | 43.245 | 39.412 | 44.874 | 64.811 | 32.173 | 31.31 | 22.965 | 23.025 | 20.36 | 22.933 | 28.252 | 33.062 | 30.395 | 34.357 | 25.685 | 21.115 | 15.525 | 13.176 | 11.951 | 9.676 | 7.742 | 5.76 | 5.003 |
| Operating Income
| -8.187 | -14.245 | -9.841 | -4.913 | -15.979 | -13.277 | -15.979 | -18.78 | -18.916 | -29.074 | -48.271 | -24.358 | -25.787 | -16.74 | -19.343 | -13.744 | -22.205 | -28.254 | -32.801 | -30.082 | -34.06 | -25.437 | -20.314 | -14.943 | -12.357 | -11.73 | -9.209 | -7.572 | -5.199 | -4.649 |
| Operating Income Ratio
| -0.17 | -0.351 | -0.222 | -0.102 | -0.42 | -0.4 | -0.42 | -0.632 | -0.747 | -1.317 | -2.253 | -2.207 | -2.895 | -2.079 | -2.729 | -1.455 | -10.955 | -15.802 | -17.597 | -93.133 | -106.438 | -102.569 | -25.361 | -25.675 | -15.088 | -44.601 | -19.719 | -44.541 | -9.202 | -13.133 |
| Total Other Income Expenses Net
| -6.069 | -4.428 | -3.785 | -7.614 | -4.538 | -3.557 | -4.538 | 0.127 | -7.608 | -5.048 | -2.519 | 0.081 | -0.01 | 0.02 | 0.055 | -0.16 | -0.039 | 0.135 | 0.152 | 0.096 | -0.108 | 0.552 | 0.133 | 0.451 | -0.306 | -0.082 | -0.015 | 0.045 | -0.032 | 0 |
| Income Before Tax
| -14.256 | -18.673 | -13.626 | -12.527 | -20.517 | -16.834 | -20.517 | -22.17 | -26.524 | -34.122 | -50.79 | -26.009 | -27.515 | -18.411 | -21.857 | -16 | -24.209 | -29.184 | -33.54 | -32.836 | -34.385 | -25.277 | -20.419 | -14.767 | -12.987 | -11.907 | -9.146 | -7.527 | -5.232 | -4.649 |
| Income Before Tax Ratio
| -0.297 | -0.459 | -0.307 | -0.259 | -0.54 | -0.507 | -0.54 | -0.746 | -1.048 | -1.546 | -2.37 | -2.357 | -3.089 | -2.287 | -3.083 | -1.693 | -11.943 | -16.322 | -17.994 | -101.659 | -107.453 | -101.923 | -25.492 | -25.373 | -15.857 | -45.274 | -19.585 | -44.276 | -9.26 | -13.133 |
| Income Tax Expense
| 0.749 | 0.307 | -0.236 | 0.338 | -0.675 | 2.751 | -0.675 | -0.339 | -0.339 | -0.408 | 1.796 | 1.798 | 1.795 | 1.791 | 4.145 | 1.945 | -0.11 | 1.179 | -0.458 | 3.507 | 1.062 | 1.063 | 0.881 | 0.737 | 0.484 | 0.191 | 0 | 0.045 | 0.001 | 0 |
| Net Income
| -15.005 | -18.98 | -13.39 | -12.189 | -19.842 | -16.834 | -19.842 | -21.831 | -26.185 | -33.714 | -50.79 | -26.009 | -27.515 | -18.411 | -21.857 | -16 | -24.099 | -29.184 | -33.082 | -32.836 | -34.385 | -25.277 | -20.419 | -14.767 | -12.987 | -11.907 | -9.146 | -7.527 | -5.232 | -4.649 |
| Net Income Ratio
| -0.312 | -0.467 | -0.302 | -0.252 | -0.522 | -0.507 | -0.522 | -0.734 | -1.035 | -1.527 | -2.37 | -2.357 | -3.089 | -2.287 | -3.083 | -1.693 | -11.889 | -16.322 | -17.748 | -101.659 | -107.453 | -101.923 | -25.492 | -25.373 | -15.857 | -45.274 | -19.585 | -44.276 | -9.26 | -13.133 |
| EPS
| -0.1 | -0.14 | -0.097 | -0.088 | -0.14 | -0.12 | -0.15 | -0.16 | -0.19 | -0.25 | -0.42 | -0.39 | -0.41 | -0.3 | -0.41 | -0.35 | -0.63 | -0.89 | -1.23 | -1.22 | -1.28 | -1.07 | -0.98 | -0.71 | -3.07 | -5.49 | -4.43 | -3.72 | -2.59 | -2.29 |
| EPS Diluted
| -0.1 | -0.14 | -0.097 | -0.088 | -0.14 | -0.12 | -0.15 | -0.16 | -0.19 | -0.25 | -0.42 | -0.39 | -0.41 | -0.3 | -0.41 | -0.35 | -0.63 | -0.89 | -1.23 | -1.22 | -1.28 | -1.07 | -0.98 | -0.71 | -3.07 | -5.49 | -4.43 | -3.72 | -2.59 | -2.29 |
| EBITDA
| -5.033 | -11.031 | -6.582 | -4.913 | -13.269 | -10.566 | -13.269 | -15.237 | -15.659 | -25.974 | -47.721 | -23.969 | -25.39 | -16.303 | -17.321 | -13.512 | -21.61 | -27.82 | -32.161 | -29.086 | -32.99 | -24.632 | -19.497 | -14.476 | -12.119 | -11.571 | -9.077 | -7.475 | -5.166 | -4.611 |
| EBITDA Ratio
| -0.105 | -0.271 | -0.148 | -0.102 | -0.349 | -0.318 | -0.349 | -0.513 | -0.619 | -1.177 | -2.227 | -2.172 | -2.851 | -2.025 | -2.443 | -1.43 | -10.661 | -15.559 | -17.254 | -90.05 | -103.094 | -99.323 | -24.341 | -24.873 | -14.797 | -43.996 | -19.437 | -43.971 | -9.143 | -13.025 |